<DOC>
	<DOCNO>NCT00470509</DOCNO>
	<brief_summary>The purpose study determine whether adalimumab ( TNF-alpha inhibitor ) effective treatment severe acute sciatica .</brief_summary>
	<brief_title>Adalimumab Severe Acute Sciatica</brief_title>
	<detailed_description>Sciatica low back pain common problem lead major cost Western country . The presence herniated disc generally consider leading cause sciatica . However , recent finding indicate presence mechanism sufficient explain clinical sign radiculopathy inflammatory mechanism contribute also pathophysiology sciatica . Indeed , herniated disc contain large amount tumor necrosis factor ( TNF-alpha ) induce acute chronic inflammation pain . It recently demonstrate TNF-alpha inhibitor ( infliximab etanercept ) able prevent occurrence pain experimental model sciatica . In addition , two independent preliminary study show patient treat TNF-alpha inhibitor good evolution historical control group . This study design verify hypothesis TNF-alpha major role human sciatica anti-TNF-alpha agent interesting therapeutic approach severe sciatica .</detailed_description>
	<mesh_term>Sciatica</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>1 . Male female patient older 18 2 . Episode radicular pain one low limb less 12 week . 3 . Medical evaluation require hospitalisation pain functional handicap 4 . Patients present characteristic leg pain L3 , L4 , L5 , S1 territories plus least one following : : positive straightlegraising test elevation le 70Â° positive femoral stretch clear clinical sign nerve root involvement muscle strength deficiency sensory disturbance clear cut dermatome low limb reflex asymmetry . 5 . Oswestry score great 50 6 . If past history radicular pain involve nerve root , 6 month interval free leg pain require . 7 . A confirmed herniated disc usual imaging technique ( CT scan MRI ) vicinity clinically involved nerve root perform within last 2 year . 8 . Written inform consent 1 . The presence recent ( &lt; 48 hour ) severe muscle weakness ( &lt; 3/5 ) clinical sign cauda equina compression , require immediate surgery . If surgical procedure require deny , either surgeon 's decision patient 's fully inform decision , patient could include protocol . 2 . Comorbidities : Coexisting infection ( Chest Xray perform patient tuberculin skin test case doubt concern past history tuberculous infection ) . Autoimmune disease ( RA ) . History cancer malign lymphoproliferative disorder ( unless patient declare remission 5 year ) History demyelinate disorder . 3 . Pregnancy . 4 . History intolerance adalimumab ingredient 5 . Previous participation clinical study . 6 . Participation another clinical study within 4 week prior start study . 7 . Poor motivation emotional intellectual problem likely limit ability patient comply protocol requirement . 8 . The use cortisone prior inclusion IS NOT exclusion criteria The investigator also allow exclude individual patient study remove blind case superimpose infection severe side effect trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>